Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending July 13, 2024 (Week 28)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 15,189 35,173 713,787 884,423
New England 119 884 19,554 22,778
Connecticut - 0 - 1,155
Maine 37 81 1,418 1,562
Massachusetts 1 647 14,049 15,133
New Hampshire - 79 1,178 1,523
Rhode Island 81 389 2,238 2,650
Vermont - 35 671 755
Middle Atlantic 2,802 4,379 98,537 106,577
New Jersey 505 788 16,726 19,231
New York (excluding New York City) 724 957 20,723 22,327
New York City 870 1,565 33,423 35,689
Pennsylvania 703 1,168 27,665 29,330
East North Central 1,709 4,727 86,278 122,829
Illinois - 1,497 16,326 37,815
Indiana 426 720 16,275 18,708
Michigan 232 1,020 15,208 22,720
Ohio 654 1,220 26,147 30,093
Wisconsin 397 533 12,322 13,493
West North Central 930 2,119 46,973 52,357
Iowa 133 313 6,343 7,437
Kansas 192 304 6,424 7,263
Minnesota 157 485 10,436 11,848
Missouri 399 724 15,901 16,430
Nebraska - 249 4,135 4,877
North Dakota 46 87 1,605 1,858
South Dakota 3 118 2,129 2,644
South Atlantic 3,759 12,279 180,170 205,454
Delaware - 227 2,616 3,084
District of Columbia 56 200 3,511 4,584
Florida 1,456 6,938 58,673 60,525
Georgia 894 1,534 31,526 39,948
Maryland 114 1,016 16,372 18,877
North Carolina 2 1,434 27,222 35,891
South Carolina 589 820 17,567 17,813
Virginia 623 934 20,487 22,406
West Virginia 25 115 2,196 2,326
East South Central 1,003 1,975 31,878 56,349
Alabama 558 895 17,096 18,196
Kentucky 340 592 8,394 8,409
Mississippi 105 1,006 6,388 11,082
Tennessee - 296 - 18,662
West South Central 616 4,788 88,871 122,032
Arkansas 189 394 8,466 9,951
Louisiana 358 799 17,314 19,645
Oklahoma 69 427 5,330 10,677
Texas - 3,280 57,761 81,759
Mountain 1,509 2,691 52,937 61,968
Arizona 410 929 20,049 21,830
Colorado 676 857 12,565 13,641
Idaho - 145 2,610 3,127
Montana 38 98 1,747 1,929
Nevada 191 357 5,960 8,424
New Mexico 17 256 3,875 6,066
Utah 158 255 5,363 5,942
Wyoming 19 52 768 1,009
Pacific 2,742 5,124 108,589 134,079
Alaska 67 125 2,616 2,796
California 2,157 3,970 89,189 104,460
Hawaii - 150 - 3,416
Oregon 205 382 7,476 8,119
Washington 313 609 9,308 15,288
U.S. Territories 2 135 667 2,777
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico 2 135 667 2,777
U.S. Virgin Islands - 0 - -
Non-U.S. Residents - 3 14 29
Total 15,191 35,217 714,468 887,229
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.